Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Wearable-Implant Diagnostics Device in Development

A university engineering lab is developing a device combining a sensor chip implanted under the skin and wrist band to diagnose serious diseases and transmit the data. . . . → Read More: Wearable-Implant Diagnostics Device in Development

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death

Simple Cell Programming Designed for Gene Therapies

A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies

App Screens for Liver Diseases with Eye Selfies

A computer science lab designed a smartphone app that detects tell-tale indicators of liver disease and pancreatic cancer by analyzing self-taken photos of a patient’s own eyes. . . . → Read More: App Screens for Liver Diseases with Eye Selfies

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Trial Testing Engineered Virus as Cancer Treatment

A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment

Alliance to Develop Rare Cancer Preclinical Models

A coalition of a patient advocacy organization, research institute, and cancer research company are implanting mice with human tumors to help study a rare form of cancer. . . . → Read More: Alliance to Develop Rare Cancer Preclinical Models

FDA Clears Algorithm-Assisted Cancer Diagnosis

The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer. . . . → Read More: FDA Clears Algorithm-Assisted Cancer Diagnosis

Patent Awarded for Exosome Capture Process

A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses. . . . → Read More: Patent Awarded for Exosome Capture Process